在急性呼吸窘迫综合征患者中,基于机器学习的Helm-CPAP治疗失败的预测
Riccardo Campi1, Antonio De Santis1, Paolo Colombo2
1Politecnico di Milano, Dipartimento di Elettronica, Informazione e Bioingegneria, Piazza Leonardo Da Vinci 32, Milano, MI, 20133, Italy.
Computer methods and programs in biomedicine
|January 9, 2025
概括
机器学习准确地预测了在急性呼吸困扰综合征 (ARDS) 患者的头盔持续正气道压力 (H-CPAP) 治疗失败. 该系统有助于管理呼吸支,改善患者的治疗结果.
科学领域:
- 肺部医学 肺部医学
- 医疗信息学 医疗信息学
- 医疗保健中的机器学习
背景情况:
- 头盔连续正气道压力 (H-CPAP) 是一种针对急性呼吸困扰综合征 (ARDS) 的非侵入性呼吸支持.
- 它的使用已经扩大到中度至严重的ARDS,特别是在COVID-19大流行期间,尽管有效性不清楚.
- 预测H-CPAP故障对于在ARDS管理中及时干预至关重要.
研究的目的:
- 开发和评估一种机器学习 (ML) 系统,用于预测ARDS患者的H-CPAP治疗失败.
- 为了利用电子医疗记录 (EMR) 进行数据驱动的预测模型.
- 加强对需要呼吸辅助的ARDS患者的临床决策.
主要方法:
- 利用了来自Vimercate医院EMR的622名ARDS患者的数据集,包括38个特征.
- 通过交叉验证训练和评估各种ML模型,包括SVM,XGBoost,神经网络,随机森林和后勤回归.
- 应用特征选择算法以优化模型性能和减少特征维度.
主要成果:
- 支持矢量机 (SVM) 和神经网络模型显示出高精度 (分别为95.19%和94.65%).
- 实现了SVM的88.61%和神经网络模型的87.18%的F1得分.
- 关键的预测特征包括PaO2/FiO2比率,C反应蛋白和O2和.
结论:
- 机器学习模型,特别是SVM和神经网络,可以有效地预测ARDS患者的H-CPAP失败.
- 功能选择可以提高模型效率,SVM和XGBoost在减少的功能集上表现良好.
- 该研究确定了预测ARDS治疗结果的关键临床参数.
相关概念视频
Acute Respiratory Failure-V
123
The treatment for acute respiratory failure varies based on factors like the underlying cause, overall health, and severity. A collaborative healthcare team is essential for early detection, often through arterial blood gas analysis. Identifying the cause is the primary goal, with treatment strategies adjusted for ventilation/perfusion (V/Q) mismatch, shunting, or diffusion impairment.
Ensure that patients are monitored continuously for their response to therapy, including changes in...
Ensure that patients are monitored continuously for their response to therapy, including changes in...
123
Acute Respiratory Failure-III
154
Hypercapnic respiratory failure, also known as Type 2 or ventilatory respiratory failure, is a severe condition characterized by the body's inability to effectively remove carbon dioxide (CO2) from the bloodstream. It leads to an arterial CO2 pressure (PaCO2) exceeding 45 mmHg and a blood pH above 7.35. This situation indicates that the body's ventilatory demand, or the ventilation needed to maintain normal PaCO2 levels, surpasses its supply or the maximum gas flow achievable without...
154
Acute Respiratory Failure-IV
125
Respiratory failure can manifest suddenly or gradually, characterized by a rapid decline in PaO2 and a rapid rise in PaCO2. This situation indicates a severe respiratory problem that may quickly become a life-threatening emergency. One of the early signs of hypoxemic Acute Respiratory Failure (ARF) is a change in mental status due to the brain's sensitivity to oxygen levels and changes in acid-base balance. Symptoms such as restlessness, confusion, and agitation suggest inadequate oxygen...
125
Mechanical Ventilation III: Noninvasive Ventilation
76
Noninvasive positive-pressure ventilation (NIPPV), continuous positive airway pressure (CPAP), and bilevel positive airway pressure (BiPAP) are essential methods in respiratory care. These ventilation techniques offer unique benefits for patients with various respiratory conditions, providing adequate support without requiring intubation. Let's explore how each method is crucial in improving patient outcomes and enhancing respiratory therapy.
Noninvasive Positive-Pressure Ventilation...
Noninvasive Positive-Pressure Ventilation...
76
Acute Respiratory Failure-I
163
Acute respiratory failure is a condition characterized by the inability of the lungs to perform their primary function: gas exchange. This failure leads to insufficient oxygen levels (hypoxemia) in the blood, elevated carbon dioxide levels (hypercapnia), or both, causing critical impairment in organ function.
Definition: It is defined by specific criteria based on blood gas measurements. Hypoxemia happens when the partial pressure of oxygen (PaO2) falls below 60 mmHg. At the same time,...
Definition: It is defined by specific criteria based on blood gas measurements. Hypoxemia happens when the partial pressure of oxygen (PaO2) falls below 60 mmHg. At the same time,...
163
Acute Respiratory Failure-II
171
Type I Respiratory Failure, or hypoxemic respiratory failure, occurs when the partial pressure of oxygen (PaO2) in arterial blood falls below 60 mmHg while breathing room air without a corresponding increase in arterial carbon dioxide levels (PaCO2). This condition highlights a significant impairment in the lungs' capacity to oxygenate the blood.
The underlying physiological abnormalities that contribute to hypoxemic respiratory failure include:
The underlying physiological abnormalities that contribute to hypoxemic respiratory failure include:
171


